Neonatal Infection
48
10
14
23
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
1 terminated out of 48 trials
95.8%
+9.3% vs benchmark
10%
5 trials in Phase 3/4
13%
3 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (48)
Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Oral Amoxicillin and Cephalexin PK/PD in Neonates
National Bacterial Meningitis Study in Children and Newborns
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
Understanding COVID-19 Infection in Pregnant Women and Their Babies
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
Peripheral Fractional Tissue Oxygen Extraction and Infection in Term and Preterm Neonates
Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections
Exploring Vancomycin Disposition in Neonates
Prenatal Antibiotics and Breast Milk / Neonatal IgA
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
COPE - COVID-19 in Pregnancy and Early Childhood
Effect of Chlorhexidine Versus Alcohol on Infections in Neonates
Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.
Parental Participation on the Neonatal Ward - the neoPARTNER Study